ArticleComputational intelligence and neuroscience2022
Effectiveness of Artificial Intelligence Models for Cardiovascular Disease Prediction: Network Meta-Analysis.
Article in Computational intelligence and neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Opportunities and Challenges of Cardiovascular Disease Risk Prediction for Primary Prevention Using Machine Learning and Electronic Health Records: A Systematic Review.Reviews in cardiovascular medicine · 2025Pooled it
- A Systematic Review of Artificial Intelligence Models for Time-to-Event Outcome Applied in Cardiovascular Disease Risk Prediction.Journal of medical systems · 2024Pooled it
- Comparative predictive performance of three machine learning algorithms for acute radiation enteritis risk among patients with cervical cancer undergoing radiotherapy: A prospective cohort study.Asia-Pacific journal of oncology nursing · 2026Article
- Explainable artificial intelligence models in predicting major cardiovascular events: insights from the PolyIran and PolyPars prospective studies.Scientific reports · 2026Article
- Machine Learning for Coronary Heart Disease Prediction: Comparative Analysis of Framingham and Cleveland Subset of the UCI Dataset with SHAP-Based Interpretability.Epidemiologia (Basel, Switzerland) · 2026Article
- Impact of artificial intelligence on cardiovascular workflow, engagement, and outcomes: a systematic review.NPJ digital medicine · 2026Article
- The Heart of Transformation: Exploring Artificial Intelligence in Cardiovascular Disease.Biomedicines · 2025Review
- Machine learning based prediction models for cardiovascular disease risk using electronic health records data: systematic review and meta-analysis.European heart journal. Digital health · 2025Review
- Development of a machine learning multiclass screening tool for periodontal health status based on non-clinical parameters and salivary biomarkers.Journal of clinical periodontology · 2024Observational
- Review
- Artificial intelligence-based framework for early detection of heart disease using enhanced multilayer perceptron.Frontiers in artificial intelligence · 2024Article
- Artificial intelligence applied in cardiovascular disease: a bibliometric and visual analysis.Frontiers in cardiovascular medicine · 2024Article
- [Advances in heart failure clinical research based on deep learning].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2023Review
- A Novel Proposal for Deep Learning-Based Diabetes Prediction: Converting Clinical Data to Image Data.Diagnostics (Basel, Switzerland) · 2023Article
- Research on System Construction and Strategy of Intelligent Sports in the Implementation of National Fitness.Computational intelligence and neuroscience · 2022Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Heart failure is the most common cause of death in both males and females around the world. Cardiovascular diseases (CVDs), in particular, are the main cause of death worldwide, accounting for 30% of all fatalities in the United States and 45% in Europe. Artificial intelligence (AI) approaches such as machine learning (ML) and deep learning (DL) models are playing an important role in the advancement of heart failure therapy. The main objective of this study was to perform a network meta-analysis of patients with heart failure, stroke, hypertension, and diabetes by comparing the ML and DL models. A comprehensive search of five electronic databases was performed using ScienceDirect, EMBASE, PubMed, Web of Science, and IEEE Xplore. The search strategy was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement. The methodological quality of studies was assessed by following the Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) guidelines. The random-effects network meta-analysis forest plot with categorical data was used, as were subgroups testing for all four types of treatments and calculating odds ratio (OR) with a 95% confidence interval (CI). Pooled network forest, funnel plots, and the league table, which show the best algorithms for each outcome, were analyzed. Seventeen studies, with a total of 285,213 patients with CVDs, were included in the network meta-analysis. The statistical evidence indicated that the DL algorithms performed well in the prediction of heart failure with AUC of 0.843 and CI [0.840-0.845], while in the ML algorithm, the gradient boosting machine (GBM) achieved an average accuracy of 91.10% in predicting heart failure. An artificial neural network (ANN) performed well in the prediction of diabetes with an OR and CI of 0.0905 [0.0489; 0.1673]. Support vector machine (SVM) performed better for the prediction of stroke with OR and CI of 25.0801 [11.4824; 54.7803]. Random forest (RF) results performed well in the prediction of hypertension with OR and CI of 10.8527 [4.7434; 24.8305]. The findings of this work suggest that the DL models can effectively advance the prediction of and knowledge about heart failure, but there is a lack of literature regarding DL methods in the field of CVDs. As a result, more DL models should be applied in this field. To confirm our findings, more meta-analysis (e.g., Bayesian network) and thorough research with a larger number of patients are encouraged.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.